Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Non-Current Assets: 2010-2021

Historic Non-Current Assets for Neurocrine Biosciences (NBIX) over the last 11 years, with Sep 2021 value amounting to $1.0 billion.

  • Neurocrine Biosciences' Non-Current Assets rose 192.62% to $1.0 billion in Q3 2021 from the same period last year, while for Sep 2021 it was $1.0 billion, marking a year-over-year increase of 192.62%. This contributed to the annual value of $718.5 million for FY2020, which is 51.26% up from last year.
  • Per Neurocrine Biosciences' latest filing, its Non-Current Assets stood at $1.0 billion for Q3 2021, which was up 19.53% from $846.3 million recorded in Q2 2021.
  • Neurocrine Biosciences' Non-Current Assets' 5-year high stood at $1.0 billion during Q3 2021, with a 5-year trough of $49.9 million in Q1 2017.
  • Its 3-year average for Non-Current Assets is $538.6 million, with a median of $393.7 million in 2020.
  • In the last 5 years, Neurocrine Biosciences' Non-Current Assets fell by 14.46% in 2017 and then spiked by 486.31% in 2018.
  • Quarterly analysis of 5 years shows Neurocrine Biosciences' Non-Current Assets stood at $262.7 million in 2017, then fell by 2.78% to $255.4 million in 2018, then surged by 86.00% to $475.0 million in 2019, then soared by 51.26% to $718.5 million in 2020, then soared by 192.62% to $1.0 billion in 2021.
  • Its Non-Current Assets stands at $1.0 billion for Q3 2021, versus $846.3 million for Q2 2021 and $761.0 million for Q1 2021.